COVID19-HCSC Study of the Immune System during infection with Coronavirus in immunocompromised and cancer patients
Principal Investigators: Dr. Silvia Sánchez Ramón, from the Immunology Service, with the collaboration of Dr. Alberto Ocaña and Dr. Pedro Pérez Segura from the Medical Oncology Service and CRIS UNIT for New Experimental Therapies Centres: Hospital Clínico San Carlos. Current situation SARS-Cov-2, the coronavirus that has led to the COVID19 epidemic, has marked a turning
COVID19-H12O, sequencing the SARS-CoV-2 Coronavirus genome in infected blood cancer patients
Principal Investigators: Dr. Joaquín Martínez from the CRIS Unit for Haematological Tumours. Centre: Hospital 12 de Octubre, Madrid Current situation Since the year 2013, the CRIS Cancer Foundation has been supporting the CRIS Unit for Haematological Tumours (HUNET-CRIS) at the Hospital 12 de October. The Unit is currently carrying out 130 clinical trials and has so far
COVID19 project – HOSPITAL LA PAZ. Cell therapy with memory T cells in patients with severe COVID19
Principal Investigators: Dr. Antonio Pérez and Cristina Ferreras from the CRIS Unit for Advanced Therapies. Centre: Hospital de La Paz, Madrid. Current situation In 2018, the CRIS Cancer Foundation funded the construction of the CRIS Unit on the 8th floor of the Maternity Wing at the Hospital Universitario de la Paz. Coordinated by Antonio Pérez Martinez, this